From understanding your sales channels to setting up monitoring services, Freeths experts Simon Barker and Fiona Lawson offer practical brand protection advice to keep your key assets away from fakers | 1mo
IP
US jury awarded tech behemoth just $250 in damages in ongoing battle with medtech rival Masimo | 1mo
The long-running IP dispute related to the Nobel Prize-winning gene editing technology CRISPR rumbles on and now extends beyond ownership, write HSF lawyers Emily Bottle and Dylan Churchill | 1mo
Jenny Davies joins as a partner in Cooley’s London life sciences partnering and licensing practice | 1mo
Californian court finds ‘strong likelihood’ that ex-employee took trade secret information to benefit his own company | 1mo
Latest lawsuits in mounting patent litigation over vaccines against the two viruses | 1mo
Arrival of Tim Powell continues US firm’s European IP push | 1mo
Collaboration with online platform Created by Humans aims to protect and monetise authors’ work in age of AI | 1mo
GSK’s two patents declared invalid as both attempt to launch first RSV vaccine in UK market | 1mo
Xiaomi’s adviser Kirkland hails ‘groundbreaking’ decision to make an interim licence available ahead of FRAND trial | 1mo
US judge grants retrial as jury’s verdict is ‘against the great weight of the evidence’ | 2mos
Decision sets a precedent as it broadens the scope of lawful data use for AI training | 2mos
Boston stalwart to shutter following raids from larger rivals | 2mos
Kaplan is a leading global financial education provider through its successful Kaplan Schweser books | 2mos
Partners James Zimmerman and Scott Palmer take team to Loeb ahead of Perkins’ Beijing closure | 2mos
Decisions from the European Patent Office and more recently the Unitary Patent Court continue to develop patent law affecting the life sciences in Europe, writes Mewburn Ellis patent lawyer Nick Sutcliffe | 2mos
Producers had opposed registration of two trademarks in long running dispute with Fontana Food | 2mos
US firm closed its Shanghai office in March | 2mos
Novartis and Genentech had accused Korean rival of “imminent infringement” through marketing of biosimilar | 2mos
Internet Archive had been sued for infringing copyright by making digital copies of print books | 2mos
Copyright 2024 © The Global Legal Post. All Rights Reserved